Libby P - Search Results

1

Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points.

Kinlay S, Selwyn AP, Delagrange D, Creager MA, Libby P, Ganz P. Kinlay S, et al. Among authors: libby p. Curr Opin Lipidol. 1996 Dec;7(6):389-97. doi: 10.1097/00041433-199612000-00009. Curr Opin Lipidol. 1996. PMID: 9117144 Review.

2

Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury.

Tanaka H, Sukhova GK, Swanson SJ, Clinton SK, Ganz P, Cybulsky MI, Libby P. Tanaka H, et al. Among authors: libby p. Circulation. 1993 Oct;88(4 Pt 1):1788-803. doi: 10.1161/01.cir.88.4.1788. Circulation. 1993. PMID: 7691431

3

Cytokines regulate vascular functions related to stability of the atherosclerotic plaque.

Libby P, Sukhova G, Lee RT, Galis ZS. Libby P, et al. J Cardiovasc Pharmacol. 1995;25 Suppl 2:S9-12. doi: 10.1097/00005344-199500252-00003. J Cardiovasc Pharmacol. 1995. PMID: 8699871 Review.

4

Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis.

Ganz P, Creager MA, Fang JC, McConnell MV, Lee RT, Libby P, Selwyn AP. Ganz P, et al. Among authors: libby p. Am J Med. 1996 Oct 8;101(4A):4A10S-16S. Am J Med. 1996. PMID: 8900332 Review.

5

Macrophages and atherosclerotic plaque stability.

Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT. Libby P, et al. Curr Opin Lipidol. 1996 Oct;7(5):330-5. doi: 10.1097/00041433-199610000-00012. Curr Opin Lipidol. 1996. PMID: 8937525 Review.

6

Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease.

Selwyn AP, Kinlay S, Libby P, Ganz P. Selwyn AP, et al. Among authors: libby p. Circulation. 1997 Jan 7;95(1):5-7. doi: 10.1161/01.cir.95.1.5. Circulation. 1997. PMID: 8994406

7

Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease.

Selwyn AP, Kinlay S, Creager M, Libby P, Ganz P. Selwyn AP, et al. Among authors: libby p. Am J Cardiol. 1997 Mar 6;79(5A):17-23. doi: 10.1016/s0002-9149(97)00125-2. Am J Cardiol. 1997. PMID: 9127617 Review.

8

Restenosis revisited--new targets, new therapies.

Libby P, Ganz P. Libby P, et al. N Engl J Med. 1997 Aug 7;337(6):418-9. doi: 10.1056/NEJM199708073370608. N Engl J Med. 1997. PMID: 9241132 No abstract available.

9

Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization.

Libby P, Schoenbeck U, Mach F, Selwyn AP, Ganz P. Libby P, et al. Am J Med. 1998 Feb 23;104(2A):14S-18S. doi: 10.1016/s0002-9343(98)00041-2. Am J Med. 1998. PMID: 9550502 Review.

10

New insights into plaque stabilisation by lipid lowering.

Libby P, Aikawa M. Libby P, et al. Drugs. 1998;56 Suppl 1:9-13; discussion 33. doi: 10.2165/00003495-199856001-00002. Drugs. 1998. PMID: 9740536 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

973 results

Search Page

Filters